MOTS-c

The short version

Why people discuss it

AxonRep’s community research repeatedly identifies interest in MOTS-c for metabolic health, exercise capacity, recovery and longevity. That agreement describes community interest; the foundational efficacy findings are mainly from cells and animals.

What it is

A 16-amino-acid signaling peptide encoded within mitochondrial DNA. CB-4211 is a synthetic MOTS-c analog studied as a separate investigational drug and should not be treated as an interchangeable product.

Biggest caution

Human evidence is limited, and there is no approved MOTS-c product or established public-use regimen. Animal doses and CB-4211 trial findings cannot supply a dosing schedule for an unverified vial.

Stack context

Community discussions often group MOTS-c with SS-31 and NAD+ as “mitochondrial support.” Their different identities and evidence do not establish a validated stack.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.